Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s529231 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Ting Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Doxorubicin, Ifosfamide, Sarcoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
- Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, People's Republic of China.
- Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
ORCID-Profile: Jing Chen
Zitieren
APA
Ye, T., Fan, L., Cao, R., Peng, L., & Chen, J. (2025). Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s529231
Vancouver
Ye T, Fan L, Cao R, Peng L, Chen J. Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s529231
BibTeX
@article{Ye2025,
author = {Ye, Ting and Fan, Li and Cao, Rubo and Peng, Ling and Chen, Jing},
title = {Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s529231}
}
EUVIMED